Literature DB >> 18322551

Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus.

M Kaplan1, P Merlob, R Regev.   

Abstract

Despite publication of guidelines for the prevention and management of hyperbilirubinemia in term and late-preterm newborn infants, kernicterus, although rare, continues to occur. Guidelines written for use in one country may not always be universally appropriate. Bearing this in mind, a committee appointed by the Israel Neonatal Society has formulated a set of guidelines, based on those of the American Academy of Pediatrics (2004), but adapted to the realities of the Israeli scene. The guidelines include methods of surveillance of jaundice, prediction of jaundice, assessment of risk factors, discharge planning and post-discharge follow-up, in addition to therapeutic guidelines including indications for phototherapy, exchange transfusion and the use of intravenous immune globulin. Availability of these guidelines to the international community may offer direction to physicians of other countries who may be setting up guidelines for use in their own communities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322551     DOI: 10.1038/jp.2008.20

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  9 in total

1.  Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates.

Authors:  Michael Kaplan; Cathy Hammerman; Hendrik J Vreman; Ronald J Wong; David K Stevenson
Journal:  J Pediatr       Date:  2010-07-02       Impact factor: 4.406

2.  Israel transcutaneous bilirubin nomogram predicts significant hyperbilirubinemia.

Authors:  R Bromiker; A Goldberg; M Kaplan
Journal:  J Perinatol       Date:  2017-08-31       Impact factor: 2.521

3.  Icterus Neonatorum in Near-Term and Term Infants: An overview.

Authors:  Rehan Ali; Shakeel Ahmed; Maqbool Qadir; Khalil Ahmad
Journal:  Sultan Qaboos Univ Med J       Date:  2012-04-09

Review 4.  Management of severe hyperbilirubinemia in the cholestatic neonate: a review and an approach.

Authors:  Jon F Watchko; M Jeffrey Maisels
Journal:  J Perinatol       Date:  2022-02-10       Impact factor: 3.225

5.  Multidisciplinary guidelines for the care of late preterm infants.

Authors:  R M Phillips; M Goldstein; K Hougland; R Nandyal; A Pizzica; A Santa-Donato; S Staebler; A R Stark; T M Treiger; E Yost
Journal:  J Perinatol       Date:  2013-07       Impact factor: 2.521

6.  Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks' gestational age.

Authors:  Costantino Romagnoli; Giovanni Barone; Simone Pratesi; Francesco Raimondi; Letizia Capasso; Enrico Zecca; Carlo Dani
Journal:  Ital J Pediatr       Date:  2014-01-31       Impact factor: 2.638

7.  Risk factors for readmission for phototherapy due to jaundice in healthy newborns: a retrospective, observational study.

Authors:  Amit Blumovich; Laurence Mangel; Sivan Yochpaz; Dror Mandel; Ronella Marom
Journal:  BMC Pediatr       Date:  2020-05-26       Impact factor: 2.125

8.  Systematic review of global clinical practice guidelines for neonatal hyperbilirubinemia.

Authors:  Meng Zhang; Jun Tang; Yang He; Wenxing Li; Zhong Chen; Tao Xiong; Yi Qu; Youping Li; Dezhi Mu
Journal:  BMJ Open       Date:  2021-01-19       Impact factor: 2.692

9.  Nomogram for Acute Bilirubin Encephalopathy Risk in Newborns With Extreme Hyperbilirubinemia.

Authors:  Yangming Qu; Shuhan Huang; Xin Fu; Youping Wang; Hui Wu
Journal:  Front Neurol       Date:  2020-11-24       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.